preclinical safety evaluation found no genotoxicity, mutagenicity, or organ toxicity at tested doses
There has been limited research examining the efficacy of BPC-157 in humans, and the peptide has yet to receive formal approval for any therapeutic use
Despite that risk, there are still easy ways to extend the shelf life of your B12 injections and keep them in good condition long after their expiration date
When to seek urgent medical advice : If you have already used an unlicensed peptide and experience any of the following, contact NHS 111 promptly or call 999 (or attend your nearest emergency department) in an emergency: Severe nausea, vomiting, or abdominal pain Signs of infection at the injection site (redness, swelling, warmth, or discharge) Dizziness, palpitations, or fainting Allergic reactions such as rash, swelling, or difficulty breathing (call 999 immediately for suspected anaphylaxis) Signs of serious infection or sepsis (high fever, confusion, rapid breathing, or feeling extremely unwell) Healthcare professionals are encouraged to take a non-judgemental approach when patients disclose use of unlicensed substances, focusing on harm reduction and signposting to regulated alternatives
The combination of B12 with lipotropic compounds does not enhance the evidence for either component
Some patients start with weekly injections, then transition to monthly maintenance once levels stabilize
